Parallel Advisors, LLC Cyma Bay Therapeutics, Inc. Transaction History

Parallel Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$12.63 - $24.47 $8,032 - $15,562	636 Added 676.6%	730 $17,000
Q3 2023 May 20, 2024	BUY	$10.86 - $17.62 $575 - $933	53 Added 129.27%	94 $1,000
Q3 2023 Nov 13, 2023	BUY	$10.86 - $17.62 $1,020 - $1,656	94 New	94 $1,000
Q1 2023 May 20, 2024	BUY	$5.88 - $9.59 $241 - $393	41 New	41 $0
Q1 2023 Apr 25, 2023	BUY	$5.88 - $9.59 $241 - $393	41 New	41 $0
Q1 2022 Apr 28, 2022	BUY	$2.77 - $3.64 $2 - $3	1 New	1 $0
Q3 2017 Nov 14, 2017	SELL	$5.95 - $8.26 $2,380 - $3,304	-400 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	400	400 $3,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.